Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hoche Partners Pharma Holding S.A. is a Luxembourg-based investment holding company, acting as a principal investor and controlling stakeholder in Procaps Group, a major Latin American pharmaceutical and healthcare firm. It is not an operating biotech/pharma manufacturer, but its investment consortium led the $130 million controlling equity restructuring of Procaps in 2024, and now directly influences Procaps’ strategy and turnaround.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hoche Partners Pharma Holding.